Northwest Biotherapeutics reported 130.01M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 163.06M 6.12M
Applied Genetic Technologies AGTC:US $ 25.81M 1.7M
AstraZeneca AZN:LN 22740M 146M
Bristol Myers Squibb BMY:US $ 22821M 953M
Celldex Therapeutics CLDX:US $ 14.56M 1.97M
Cti Biopharma CTIC:US $ 98.93M 32.28M
Cytori Therapeutics CYTX:US $ 4.92M 0.95M
Cytrx CYTR:US 3.1M 633.56K
Eisai 4523:JP Y 313333M 8340M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Infinity Pharmaceuticals INFI:US $ 13.39M 0.09M
Merk MRK:US $ 22316M 1556M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Northwest Biotherapeutics NWBO:US 130.01M 3.76M
Pfizer PFE:US $ 39268M 3403M